Room Temp Advantage Position REVOX as a low-temperature sterilization alternative that reduces pre-conditioning and aeration, appealing to manufacturers seeking faster onboarding and reduced process cycles for sensitive devices.

On-Site Processing Highlight capability for multiple chamber configurations and on-site sterilization to cut logistics, storage, and turnaround times, creating cost- and time-to-market benefits for medical device manufacturers.

Contract Services Leverage fast turn-around contract sterilization services to target CROs and device makers needing scalable, validated sterilization solutions with clear project objectives and milestones.

FDA Validation Edge Emphasize FDA clearance for the REVOX process to reduce regulatory risk for customers pursuing implantable and other sensitive devices, accelerating product approvals and market access.

Low Residuals Promote the chemistry profile that yields no harmful residuals and breakdown to benign byproducts, appealing to quality and compliance teams prioritizing cleaner sterilization processes.